Vallon Pharmaceuticals, Inc. (NASDAQ:VLON – Get Rating) was the recipient of a large decrease in short interest in March. As of March 15th, there was short interest totalling 224,600 shares, a decrease of 80.1% from the February 28th total of 1,130,000 shares. Based on an average daily trading volume, of 6,710,000 shares, the days-to-cover ratio […]